Navigated to August 2025: Telehealth Prescribing of Stimulants for ADHD and Associated Risk for Later Stimulant and Substance Use Disorders

August 2025: Telehealth Prescribing of Stimulants for ADHD and Associated Risk for Later Stimulant and Substance Use Disorders

August 1
33 mins

View Transcript

Episode Description

Dr. Vinod Rao (Massachusetts General Hospital, Boston) join AJP Audio to discuss predicting the relative risk of patients with an ADHD diagnosis developing a later stimulant or substance use disorder based on the method of prescription, in person or via telehealth. Afterwards, AJP Editor-in-Chief Dr. Ned Kalin discusses the rest of the August issue of the Journal.

  • 00:07   Rao interview
  • 01:53   Stimulant use disorder versus substance use disorder
  • 02:59   Cohort size and incidence of SUDs
  • 04:28   Length of clinician engagement in non-profit versus for profit hospital systems
  • 05:18   Patient cohort
  • 06:20   Potential difference in mechanism between prescribing practices
  • 07:35   Continued use of telehealth
  • 08:43   Limitations
  • 10:03   Further research
  • 11:17   Kalin interview
  • 11:24   Rao et al.
  • 15:41   Mahjani et al.
  • 19:59   Zhang et al.
  • 25:11   Sha et al.
  • 29:33   Gao and Olfson

Transcript

Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.

Subscribe to the podcast here.

Listen to other podcasts produced by the American Psychiatric Association.

Browse articles online.

How authors may submit their work.

Follow the journals of APA Publishing on Twitter.

E-mail us at ajp@psych.org

See all episodes

Never lose your place, on any device

Create a free account to sync, back up, and get personal recommendations.